| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.3 |